Goldman Sachs estimates that AI drug discovery and breakthroughs like gene editing will add 0.5% to 2.5% to the U.S. gross ...
Meanwhile, Eli Lilly's weight loss drug Zepbound and diabetes treatment ... Latest in health-care tech: Doctors seeing benefits from AI, but feel pessimistic about the future of the U.S. health ...
Novo Nordisk is taking aim at its rival, Eli Lilly, with a new obesity drug deal. On Monday ... Doctors seeing benefits from AI, but feel pessimistic about the future of the U.S. health-care ...
Eli Lilly and Co. (LLY ... The agreement combines Absci’s generative AI drug creation platform and its antibody design models with Owkin’s predictive AI models to cut research and development ...
Schneider Electric to invest over $700 million in US to power AI boom Schneider Electric ... March 21, 2025 Eli Lilly launches weight-loss drug Mounjaro in India, beats Novo Nordisk to major ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results